|
1
|
Lefranc F, Sadeghi N, Camby I, Metens T,
Dewitte O and Kiss R: Present and potential future issues in
glioblastoma treatment. Expert Rev Anticancer Ther. 6:719–732.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mathieu V, de Lassalle EM, Toelen J, Mohr
T, Bellahcène A, Van Goietsenoven G, Verschuere T, Bouzin C,
Debyser Z, De Vleeschouwer S, et al: Galectin-1 in melanoma biology
and related neo-angiogenesis processes. J Invest Dermatol.
132:2245–2254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Newman DJ and Giddings LA: Natural
products as leads to antitumor drugs. Phytochem Rev. 13:123–137.
2014. View Article : Google Scholar
|
|
4
|
Shen L, Kondo Y, Ahmed S, Boumber Y,
Konishi K, Guo Y, Chen X, Vilaythong JN and Issa JP: Drug
sensitivity prediction by CpG island methylation profile in the
NCI-60 cancer cell line panel. Cancer Res. 67:11335–11343. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dittmann LM, Danner A, Gronych J, Wolter
M, Stühler K, Grzendowski M, Becker N, Bageritz J, Goidts V, Toedt
G, et al: Downregulation of RDX1 by promoter hypermethylation is
frequent in 1p/19q-deleted oligodendroglial tumours and increases
radio- and chemosensitivity of Hs683 glioma cells in vitro.
Oncogene. 31:3409–3418. 2012. View Article : Google Scholar
|
|
6
|
Bury M, Novo-Uzal E, Andolfi A, Cimini S,
Wauthoz N, Heffeter P, Lallemand B, Avolio F, Delporte C, Cimmino
A, et al: Ophiobolin A, a sesterterpenoid fungal phytotoxin,
displays higher in vitro growth-inhibitory effects in mammalian
than in plant cells and displays in vivo antitumor activity. Int J
Oncol. 43:575–585. 2013.PubMed/NCBI
|
|
7
|
Bury M, Girault A, Mégalizzi V,
Spiegl-Kreinecker S, Mathieu V, Berger W, Evidente A, Kornienko A,
Gailly P, Vandier C, et al: Ophiobolin A induces paraptosis-like
cell death in human glioblastoma cells by decreasing BKCa channel
activity. Cell Death Dis. 4:e5612013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Morrison R, Gardiner C, Evidente A, Kiss R
and Townley H: Incorporation of ophiobolin a into novel
chemoembolization particles for cancer cell treatment. Pharm Res.
31:2904–2917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
de Vries-van Leeuwen IJ,
Kortekaas-Thijssen C, Nzigou Mandouckou JA, Kas S, Evidente A and
de Boer AH: Fusicoccin-A selectively induces apoptosis in tumor
cells after interferon-alpha priming. Cancer Lett. 293:198–206.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dasari R, Masi M, Lisy R, Ferdérin M,
English LR, Cimmino A, Mathieu V, Brenner AJ, Kuhn JG, Whitten ST,
et al: Fungal metabolite ophiobolin A as a promising anti-glioma
agent: In vivo evaluation, structure-activity relationship and
unique pyrrolylation of primary amines. Bioorg Med Chem Lett.
25:4544–4548. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Evidente A, Andolfi A, Cimmino A, Vurro M,
Fracchiolla M and Charudattan R: Herbicidal potential of
ophiobolins produced by Drechslera gigantea. J Agric Food Chem.
54:1779–1783. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Evidente A, Kornienko A, Lefranc F,
Cimmino A, Dasari R, Evidente M, Mathieu V and Kiss R:
Sesterterpenoids with anticancer activity. Curr Med Chem.
22:3502–3522. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kong Au T and Chow Leung P: Identification
of the binding and inhibition sites in the calmodulin molecule for
ophiobolin A by site-directed mutagenesis. Plant Physiol.
118:965–973. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leung PC, Taylor WA, Wang JH and Tipton
CL: Ophiobolin A -A natural product inhibitor of calmodulin. J Biol
Chem. 259:2742–2747. 1984.PubMed/NCBI
|
|
15
|
Leung PC, Taylor WA, Wang JH and Tipton
CL: Role of calmodulin inhibition in the mode of action of
ophiobolin a. Plant Physiol. 77:303–308. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujiwara H, Matsunaga K, Kumagai H,
Ishizuka M and Ohizumi Y: Ophiobolin A, a novel apoptosis-inducing
agent from fungus strain f-7438. Pharm Pharmacol Commun. 6:427–431.
2000. View Article : Google Scholar
|
|
17
|
Heizmann CW, Berchtold MW and Sommer EW:
Regulation of calcium in tumor cells. Prog Clin Biol Res.
252:391–394. 1988.PubMed/NCBI
|
|
18
|
Klug M, Blum JK, Ye Q and Berchtold MW:
Intracellular Ca2+ and Ca2+-binding proteins
in chemically transformed rat fibroblasts. Exp Cell Res.
213:313–318. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Török K, Wilding M, Groigno L, Patel R and
Whitaker M: Imaging the spatial dynamics of calmodulin activation
during mitosis. Curr Biol. 8:692–699. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Persechini A and Cronk B: The relationship
between the free concentrations of Ca2+ and
Ca2+-calmodulin in intact cells. J Biol Chem.
274:6827–6830. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Berchtold MW and Villalobo A: The many
faces of calmodulin in cell proliferation, programmed cell death,
autophagy, and cancer. Biochim Biophys Acta. 1843:398–435. 2014.
View Article : Google Scholar
|
|
22
|
Galluzzi L, Vitale I, Abrams JM, Alnemri
ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry
WS, Fulda S, et al: Molecular definitions of cell death
subroutines: Recommendations of the Nomenclature Committee on Cell
Death 2012. Cell Death Differ. 19:107–120. 2012. View Article : Google Scholar :
|
|
23
|
Nagaraja GM, Othman M, Fox BP, Alsaber R,
Pellegrino CM, Zeng Y, Khanna R, Tamburini P, Swaroop A and Kandpal
RP: Gene expression signatures and biomarkers of noninvasive and
invasive breast cancer cells: Comprehensive profiles by
representational difference analysis, microarrays and proteomics.
Oncogene. 25:2328–2338. 2006. View Article : Google Scholar
|
|
24
|
Rapa E, Hill SK, Morten KJ, Potter M and
Mitchell C: The over-expression of cell migratory genes in alveolar
rhabdomyosarcoma could contribute to metastatic spread. Clin Exp
Metastasis. 29:419–429. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Canal F, Vicent MJ, Pasut G and Schiavon
O: Relevance of folic acid/polymer ratio in targeted PEG-epirubicin
conjugates. J Control Release. 146:388–399. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Galluzzi L, Kepp O, Krautwald S, Kroeme
and Linkermann A: Molecular mechanisms of regulated necrosis. Semin
Cell Dev Biol. 35:24–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
ATTC: 2014, ATCC cell lines by gene
mutation [Online]. Available: http://www.atcc.org.
|
|
28
|
Hinson A, Jones R, Crose L, Belyea B, Barr
F and Linardic C: Human rhabdomyosarcoma cell lines for
rhabdomyosarcoma research:Utility and pitfalls. Front Oncol.
3:1832013. View Article : Google Scholar
|
|
29
|
Morse D, Gray H, Payne C and Gillies R:
Docetaxel induces cell death through mitotic catastrophe in human
breast cancer cells. Mol Cancer Ther. 4:1495–1504. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Landry J, Pyl P, Rausch T, Zichner T,
Tekkedil M, Stutz A, Jauch A, Aiyar R, Pau G, Delhomme N, et al:
The genomic and transcriptomic landscape of a HeLa cell line G3. G3
(Bethesda). 1213–1224. 2013. View Article : Google Scholar
|
|
31
|
Majno G and Joris I: Apoptosis, oncosis,
and necrosis. An overview of cell death. Am J Pathol. 146:3–15.
1995.PubMed/NCBI
|
|
32
|
Beckman KB and Ames BN: The free radical
theory of aging matures. Physiol Rev. 78:547–581. 1998.PubMed/NCBI
|
|
33
|
Rizzuto R, Pinton P, Carrington W, Fay FS,
Fogarty KE, Lifshitz LM, Tuft RA and Pozzan T: Close contacts with
the endoplasmic reticulum as determinants of mitochondrial
Ca2+ responses. Science. 280:1763–1766. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bravo R, Parra V, Gatica D, Rodriguez AE,
Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E,
et al: Endoplasmic reticulum and the unfolded protein response:
Dynamics and metabolic integration. Int Rev Cell Mol Biol.
301:215–290. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Le Mercier M, Mathieu V, Haibe-Kains B,
Bontempi G, Mijatovic T, Decaestecker C, Kiss R and Lefranc F:
Knocking down galectin 1 in human hs683 glioblastoma cells impairs
both angiogenesis and endoplasmic reticulum stress responses. J
Neuropathol Exp Neurol. 67:456–469. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mathieu V, Chantôme A, Lefranc F, Cimmino
A, Miklos W, Paulitschke V, Mohr T, Maddau L, Kornienko A, Berger
W, et al: Sphaeropsidin A shows promising activity against
drug-resistant cancer cells by targeting regulatory volume
increase. Cell Mol Life Sci. 72:3731–3746. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Okada Y, Maeno E, Shimizu T, Dezaki K,
Wang J and Morishima S: Receptor-mediated control of regulatory
volume decrease (RVD) and apoptotic volume decrease (AVD). J
Physiol. 532:3–16. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Florea AM and Büsselberg D: Cisplatin as
an anti-tumor drug: Cellular mechanisms of activity, drug
resistance and induced side effects. Cancers (Basel). 3:1351–1371.
2011. View Article : Google Scholar
|
|
39
|
Gronski MA, Kinchen JM, Juncadella IJ,
Franc NC and Ravichandran KS: An essential role for calcium flux in
phagocytes for apoptotic cell engulfment and the anti-inflammatory
response. Cell Death Differ. 16:1323–1331. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kasim NR, Kuželová K, Holoubek A and Model
MA: Live fluorescence and transmission-through-dye microscopic
study of actinomycin D-induced apoptosis and apoptotic volume
decrease. Apoptosis. 18:521–532. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
LC50 mean graph for compound 114340. Sept.
2014, Available: https://dtp.cancer.gov/dtpstandard/subsets/comp.jsp.
|
|
42
|
Reinhold WC, Sunshine M, Liu H, Varma S,
Kohn KW, Morris J, Doroshow J and Pommier Y: CellMiner: A web-based
suite of genomic and pharmacologic tools to explore transcript and
drug patterns in the NCI-60 cell line set. Cancer Res.
72:3499–3511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Locato V, Uzal E, Cimini S, Zonno M,
Evidente A, Micera A, Foyer C and De Gara L: Low concentrations of
the toxin ophiobolin A lead to an arrest of the cell cycle and
alter the intracellular partitioning of glutathione between the
nuclei and cytoplasm. J Exp Bot. 66:2991–3000. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Atlante A, Calissano P, Bobba A, Azzariti
A, Marra E and Passarella S: Cytochrome c is released from
mitochondria in a reactive oxygen species (ROS)-dependent fashion
and can operate as a ROS scavenger and as a respiratory substrate
in cerebellar neurons undergoing excitotoxic death. J Biol Chem.
275:37159–37166. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Behar SM, Martin CJ, Booty MG, Nishimura
T, Zhao X, Gan HX, Divangahi M and Remold HG: Apoptosis is an
innate defense function of macrophages against Mycobacterium
tuberculosis. Mucosal Immunol. 4:279–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bencsik O, Papp T, Berta M, Zana A, Forgó
P, Dombi G, Andersson MA, Salkinoja-Salonen M, Vágvölgyi C and
Szekeres A: Ophiobolin A from Bipolaris oryzae perturbs motility
and membrane integrities of porcine sperm and induces cell death on
mammalian somatic cell lines. Toxins (Basel). 6:2857–2871. 2014.
View Article : Google Scholar
|
|
48
|
Liu H, Zhao S, Zhang Y, Wu J, Peng H, Fan
J and Liao J: Reactive oxygen species-mediated endoplasmic
reticulum stress and mitochondrial dysfunction contribute to
polydatin-induced apoptosis in human nasopharyngeal carcinoma CNE
cells. J Cell Biochem. 112:3695–3703. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schonthal AH: Targeting endoplasmic
reticulum stress for cancer therapy. Front Biosci (Schol Ed).
4:412–431. 2012. View
Article : Google Scholar
|
